An upcoming international position statement will clarify the small number of patients for whom the MiniMed Implantable Infusion Pump might be considered appropriate.

Sequel Med Tech today announced the broad availability of its twiist automated insulin delivery system in the U.S.

Unexplained hyperglycemic events may be due to undetected occlusions, a common problem that experts say needs to be addressed through education and technology.

Insulet estimates that the pods involved in this correction represent approximately 1.5% of annual production globally.

Altitude changes during commercial flights may affect the blood glucose levels of people with type 1 diabetes who are treated with insulin pump therapy, according to new research to be presented at ...

Personalized therapies for diabetes, while showing promise in international studies, is met with healthy skepticism from ...